Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2017

09.11.2016 | Gynecologic Oncology

Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy

verfasst von: Vasileios D. Sioulas, MD, Soledad Jorge, MD, Jing-Yi Chern, MD, Maria B. Schiavone, MD, Martin R. Weiser, MD, Joanne F. Kelvin, MD, Ginger J. Gardner, MD, Yukio Sonoda, MD, Nadeem R. Abu-Rustum, MD, Karyn A. Goodman, MD, Mario M. Leitao Jr., MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Pelvic radiotherapy (RT) is a standard component of the management for patients with locally advanced rectal cancer or squamous cell carcinoma of the anus. Pelvic RT leads to permanent and irreversible ovarian failure in young women. This study aimed to determine the effectiveness of robotically assisted laparoscopic ovarian transposition (OT) before RT in women with rectal or anal cancer who wanted to preserve normal ovarian function.

Methods

The study reviewed the medical records of all patients treated at our institution from August 2009 to October 2014 who received robotically assisted laparoscopic OT for rectal or anal cancer before RT. Clinical and hormonal data were abstracted to determine ovarian function.

Results

The study identified 22 women with rectal (n = 20) or anal (n = 2) cancer. The median age of the women was 39 years (range 26–45 years). For one patient, OT was technically not feasible. The postoperative course was uneventful in all but one case. Follow-up data on ovarian function were unavailable for 3 patients. The median times from RT initiation to the last gynecologic or hormonal evaluation were 9 months (range 5–47 months) and 10.5 months (range 5–47 months), respectively. At the last gynecologic or hormonal follow-up visit, ovarian function was preserved in 12 (67%) of 18 evaluable patients, including 9 (90%) of 10 patients 40 years of age or younger and 3 (38%) of 8 patients older than 40 years (P = 0.07).

Conclusions

Robotically assisted laparoscopic bilateral OT is safe and can lead to preservation of ovarian function in two-thirds of patients with low gastrointestinal cancer undergoing pelvic RT. It should be considered in this setting, especially for women age 40 years or younger, to avoid premature menopause and its associated sequelae.
Literatur
1.
2.
3.
Zurück zum Zitat Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116:4354–9.CrossRefPubMedPubMedCentral Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116:4354–9.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150:17–22.CrossRefPubMedPubMedCentral Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010. JAMA Surg. 2015;150:17–22.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the U. S. Cancer. 2008;113(10 Suppl):2892–900.CrossRefPubMedPubMedCentral Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the U. S. Cancer. 2008;113(10 Suppl):2892–900.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol. 2013;31:1569–75.CrossRefPubMedPubMedCentral Nelson RA, Levine AM, Bernstein L, Smith DD, Lai LL. Changing patterns of anal canal carcinoma in the United States. J Clin Oncol. 2013;31:1569–75.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28:558–62.CrossRefPubMed O’Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28:558–62.CrossRefPubMed
9.
Zurück zum Zitat Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14:2759–65.CrossRefPubMed Quah HM, Joseph R, Schrag D, et al. Young age influences treatment but not outcome of colon cancer. Ann Surg Oncol. 2007;14:2759–65.CrossRefPubMed
10.
Zurück zum Zitat Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30:4344–51.CrossRefPubMedPubMedCentral Gunderson LL, Winter KA, Ajani JA, et al. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012;30:4344–51.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Torrealday S, Pal L. Premature menopause. Endocrinol Metab Clin N Am. 2015;44:543–57.CrossRef Torrealday S, Pal L. Premature menopause. Endocrinol Metab Clin N Am. 2015;44:543–57.CrossRef
12.
Zurück zum Zitat Wan J, Gai Y, Li G, Tao Z, Zhang Z. Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin Colorectal Cancer. 2015; 14:31–4.CrossRefPubMed Wan J, Gai Y, Li G, Tao Z, Zhang Z. Incidence of chemotherapy- and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer. Clin Colorectal Cancer. 2015; 14:31–4.CrossRefPubMed
13.
Zurück zum Zitat Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003;188:367–70.CrossRefPubMed Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003;188:367–70.CrossRefPubMed
14.
Zurück zum Zitat Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.CrossRefPubMed Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–10.CrossRefPubMed
16.
Zurück zum Zitat Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304–12.CrossRefPubMedPubMedCentral Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys. 2009;73:1304–12.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Vassilakopoulou M, Boostandoost E, Papaxoinis G, de La Rouge TM, Khayat D, Psyrri A. Anticancer treatment and fertility: effect of therapeutic modalities on reproductive system and functions. Crit Rev Oncol Hematol. 2016;97:328–34.CrossRefPubMed Vassilakopoulou M, Boostandoost E, Papaxoinis G, de La Rouge TM, Khayat D, Psyrri A. Anticancer treatment and fertility: effect of therapeutic modalities on reproductive system and functions. Crit Rev Oncol Hematol. 2016;97:328–34.CrossRefPubMed
18.
Zurück zum Zitat Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–21.CrossRefPubMed Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–21.CrossRefPubMed
19.
Zurück zum Zitat Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535–43.CrossRefPubMed Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535–43.CrossRefPubMed
20.
Zurück zum Zitat Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–44.CrossRefPubMed Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–44.CrossRefPubMed
21.
Zurück zum Zitat Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D. Female fertility and colorectal cancer. Int J Colorectal Dis. 2008;23:735–43.CrossRefPubMed Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D. Female fertility and colorectal cancer. Int J Colorectal Dis. 2008;23:735–43.CrossRefPubMed
22.
Zurück zum Zitat O’Neill MT, Ni Dhonnchu T, Brannigan AE. Topic update: effects of colorectal cancer treatments on female fertility and potential methods for fertility preservation. Dis Colon Rectum. 2011;54:363–9.CrossRefPubMed O’Neill MT, Ni Dhonnchu T, Brannigan AE. Topic update: effects of colorectal cancer treatments on female fertility and potential methods for fertility preservation. Dis Colon Rectum. 2011;54:363–9.CrossRefPubMed
23.
Zurück zum Zitat Azem F, Amit A, Merimsky O, Lessing JB. Successful transfer of frozen-thawed embryos obtained after subtotal colectomy for colorectal cancer and before fluorouracil-based chemotherapy. Gynecol Oncol. 2004;93:263–5.CrossRefPubMed Azem F, Amit A, Merimsky O, Lessing JB. Successful transfer of frozen-thawed embryos obtained after subtotal colectomy for colorectal cancer and before fluorouracil-based chemotherapy. Gynecol Oncol. 2004;93:263–5.CrossRefPubMed
24.
Zurück zum Zitat Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv. 2007;62:58–72.CrossRefPubMed Marhhom E, Cohen I. Fertility preservation options for women with malignancies. Obstet Gynecol Surv. 2007;62:58–72.CrossRefPubMed
25.
Zurück zum Zitat Levi M, Shalgi R, Brenner B, et al. The impact of oxaliplatin on the gonads: from bedside to the bench. Mol Hum Reprod. 2015;21:885–93.CrossRefPubMed Levi M, Shalgi R, Brenner B, et al. The impact of oxaliplatin on the gonads: from bedside to the bench. Mol Hum Reprod. 2015;21:885–93.CrossRefPubMed
26.
Zurück zum Zitat Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clin Colorectal Cancer. 2013;12:163–7.CrossRefPubMed Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Clin Colorectal Cancer. 2013;12:163–7.CrossRefPubMed
27.
Zurück zum Zitat Tulandi T, Al-Took S. Laparoscopic ovarian suspension before irradiation. Fertil Steril. 1998;70:381–3.CrossRefPubMed Tulandi T, Al-Took S. Laparoscopic ovarian suspension before irradiation. Fertil Steril. 1998;70:381–3.CrossRefPubMed
28.
Zurück zum Zitat Elizur SE, Tulandi T, Meterissian S, Huang JY, Levin D, Tan SL. Fertility preservation for young women with rectal cancer: a combined approach from one referral center. J Gastrointest Surg. 2009;13:1111–5.CrossRefPubMed Elizur SE, Tulandi T, Meterissian S, Huang JY, Levin D, Tan SL. Fertility preservation for young women with rectal cancer: a combined approach from one referral center. J Gastrointest Surg. 2009;13:1111–5.CrossRefPubMed
29.
Zurück zum Zitat Kurt M, Uncu G, Cetintas SK, Kucuk N, Guler S, Ozkan L. Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition. Eur J Gynaecol Oncol. 2007;28:408–10.PubMed Kurt M, Uncu G, Cetintas SK, Kucuk N, Guler S, Ozkan L. Successful spontaneous pregnancy in a patient with rectal carcinoma treated with pelvic radiotherapy and concurrent chemotherapy: the unique role of laparoscopic lateral ovary transposition. Eur J Gynaecol Oncol. 2007;28:408–10.PubMed
30.
Zurück zum Zitat Al-Badawi IA, Al-Aker M, AlSubhi J, et al. Laparoscopic ovarian transposition before pelvic irradiation: a Saudi tertiary center experience. Int J Gynecol Cancer. 2010;20:1082–6.CrossRefPubMed Al-Badawi IA, Al-Aker M, AlSubhi J, et al. Laparoscopic ovarian transposition before pelvic irradiation: a Saudi tertiary center experience. Int J Gynecol Cancer. 2010;20:1082–6.CrossRefPubMed
31.
Zurück zum Zitat Al-Asari S, Abduljabbar A. Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility. Ann Surg Innov Res. 2012;6:9.CrossRefPubMedPubMedCentral Al-Asari S, Abduljabbar A. Laparoscopic ovarian transposition before pelvic radiation in rectal cancer patient: safety and feasibility. Ann Surg Innov Res. 2012;6:9.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Barahmeh S, Al Masri M, Badran O, et al. Ovarian transposition before pelvic irradiation: indications and functional outcome. J Obstet Gynaecol Res. 2013;39:1533–7.CrossRefPubMed Barahmeh S, Al Masri M, Badran O, et al. Ovarian transposition before pelvic irradiation: indications and functional outcome. J Obstet Gynaecol Res. 2013;39:1533–7.CrossRefPubMed
33.
Zurück zum Zitat Treissman MJ, Miller D, McComb PF. Laparoscopic lateral ovarian transposition. Fertil Steril. 1996;65:1229–31.CrossRefPubMed Treissman MJ, Miller D, McComb PF. Laparoscopic lateral ovarian transposition. Fertil Steril. 1996;65:1229–31.CrossRefPubMed
34.
Zurück zum Zitat Gomez-Hidalgo NR, Darin MD, Dalton H, et al. Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases. J Minim Invasive Gynecol. 2015;22:687–90.CrossRefPubMed Gomez-Hidalgo NR, Darin MD, Dalton H, et al. Ovarian torsion after laparoscopic ovarian transposition in patients with gynecologic cancer: a report of two cases. J Minim Invasive Gynecol. 2015;22:687–90.CrossRefPubMed
35.
Zurück zum Zitat Picone O, Aucouturier JS, Louboutin A, Coscas Y, Camus E. Abdominal wall metastasis of a cervical adenocarcinoma at the laparoscopic trocar insertion site after ovarian transposition: case report and review of the literature. Gynecol Oncol. 2003;90:446–9.CrossRefPubMed Picone O, Aucouturier JS, Louboutin A, Coscas Y, Camus E. Abdominal wall metastasis of a cervical adenocarcinoma at the laparoscopic trocar insertion site after ovarian transposition: case report and review of the literature. Gynecol Oncol. 2003;90:446–9.CrossRefPubMed
36.
Zurück zum Zitat van Beurden M, Schuster-Uitterhoeve AL, Lammes FB. Feasibility of transposition of the ovaries in the surgical and radiotherapeutical treatment of cervical cancer. Eur J Surg Oncol. 1990;16:141–6.PubMed van Beurden M, Schuster-Uitterhoeve AL, Lammes FB. Feasibility of transposition of the ovaries in the surgical and radiotherapeutical treatment of cervical cancer. Eur J Surg Oncol. 1990;16:141–6.PubMed
37.
Zurück zum Zitat Hwang JH, Yoo HJ, Park SH, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril. 2012;97:1387–93. e1–2.CrossRefPubMed Hwang JH, Yoo HJ, Park SH, et al. Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril. 2012;97:1387–93. e1–2.CrossRefPubMed
38.
Zurück zum Zitat Soda I, Ishiyama H, Ono S, et al. Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy? J Radiat Res. 2015;56:354–9.CrossRefPubMedPubMedCentral Soda I, Ishiyama H, Ono S, et al. Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy? J Radiat Res. 2015;56:354–9.CrossRefPubMedPubMedCentral
Metadaten
Titel
Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy
verfasst von
Vasileios D. Sioulas, MD
Soledad Jorge, MD
Jing-Yi Chern, MD
Maria B. Schiavone, MD
Martin R. Weiser, MD
Joanne F. Kelvin, MD
Ginger J. Gardner, MD
Yukio Sonoda, MD
Nadeem R. Abu-Rustum, MD
Karyn A. Goodman, MD
Mario M. Leitao Jr., MD
Publikationsdatum
09.11.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5650-0

Weitere Artikel der Ausgabe 1/2017

Annals of Surgical Oncology 1/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.